BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 9060530)

  • 1. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
    Spitz FR; Abbruzzese JL; Lee JE; Pisters PW; Lowy AM; Fenoglio CJ; Cleary KR; Janjan NA; Goswitz MS; Rich TA; Evans DB
    J Clin Oncol; 1997 Mar; 15(3):928-37. PubMed ID: 9060530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.
    Pisters PW; Abbruzzese JL; Janjan NA; Cleary KR; Charnsangavej C; Goswitz MS; Rich TA; Raijman I; Wolff RA; Lenzi R; Lee JE; Evans DB
    J Clin Oncol; 1998 Dec; 16(12):3843-50. PubMed ID: 9850029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.
    Breslin TM; Hess KR; Harbison DB; Jean ME; Cleary KR; Dackiw AP; Wolff RA; Abbruzzese JL; Janjan NA; Crane CH; Vauthey JN; Lee JE; Pisters PW; Evans DB
    Ann Surg Oncol; 2001 Mar; 8(2):123-32. PubMed ID: 11258776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms.
    Evans OB; Abbruzzese JL; Cleary KR; Lee JE; Buchholz DJ; Rich TA
    J R Coll Surg Edinb; 1995 Oct; 40(5):319-23. PubMed ID: 8523311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation.
    Evans DB; Abbruzzese JL; Cleary KR; Buchholz DJ; Fenoglio CJ; Collier C; Rich TA
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):913-8. PubMed ID: 7591902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head.
    Staley CA; Lee JE; Cleary KR; Abbruzzese JL; Fenoglio CJ; Rich TA; Evans DB
    Am J Surg; 1996 Jan; 171(1):118-24; discussion 124-5. PubMed ID: 8554125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Picozzi VJ; Kozarek RA; Traverso LW
    Am J Surg; 2003 May; 185(5):476-80. PubMed ID: 12727570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
    Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
    Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
    Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.
    Pisters PW; Wolff RA; Janjan NA; Cleary KR; Charnsangavej C; Crane CN; Lenzi R; Vauthey JN; Lee JE; Abbruzzese JL; Evans DB
    J Clin Oncol; 2002 May; 20(10):2537-44. PubMed ID: 12011133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
    Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
    Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
    Pisters PW; Hudec WA; Lee JE; Raijman I; Lahoti S; Janjan NA; Rich TA; Crane CH; Lenzi R; Wolff RA; Abbruzzese JL; Evans DB
    J Clin Oncol; 2000 Feb; 18(4):860-7. PubMed ID: 10673529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas.
    Mehta VK; Fisher G; Ford JA; Poen JC; Vierra MA; Oberhelman H; Niederhuber J; Bastidas JA
    J Gastrointest Surg; 2001; 5(1):27-35. PubMed ID: 11309645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.
    Breslin TM; Janjan NA; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Evans DB
    Front Biosci; 1998 Nov; 3():E193-203. PubMed ID: 9792895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas.
    Evans DB; Pisters PW; Lee JE; Bold RJ; Charnsangavej C; Janjan NA; Wolff RA; Abbruzzese JL
    J Hepatobiliary Pancreat Surg; 1998; 5(3):242-50. PubMed ID: 9880770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer.
    Penberthy DR; Rich TA; Shelton CH; Adams R; Minasi JS; Jones RS
    Ann Oncol; 2001 May; 12(5):681-4. PubMed ID: 11432628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality management of localized pancreatic cancer.
    Wayne JD; Wolff RA; Pisters PW; Evans DB
    Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.